Literature DB >> 23974118

Co-existence of distinct prion types enables conformational evolution of human PrPSc by competitive selection.

Tracy Haldiman1, Chae Kim, Yvonne Cohen, Wei Chen, Janis Blevins, Liuting Qing, Mark L Cohen, Jan Langeveld, Glenn C Telling, Qingzhong Kong, Jiri G Safar.   

Abstract

The unique phenotypic characteristics of mammalian prions are thought to be encoded in the conformation of pathogenic prion proteins (PrP(Sc)). The molecular mechanism responsible for the adaptation, mutation, and evolution of prions observed in cloned cells and upon crossing the species barrier remains unsolved. Using biophysical techniques and conformation-dependent immunoassays in tandem, we isolated two distinct populations of PrP(Sc) particles with different conformational stabilities and aggregate sizes, which frequently co-exist in the most common human prion disease, sporadic Creutzfeldt-Jakob disease. The protein misfolding cyclic amplification replicates each of the PrP(Sc) particle types independently and leads to the competitive selection of those with lower initial conformational stability. In serial propagation with a nonglycosylated mutant PrP(C) substrate, the dominant PrP(Sc) conformers are subject to further evolution by natural selection of the subpopulation with the highest replication rate due to its lowest stability. Cumulatively, the data show that sporadic Creutzfeldt-Jakob disease PrP(Sc) is not a single conformational entity but a dynamic collection of two distinct populations of particles. This implies the co-existence of different prions, whose adaptation and evolution are governed by the selection of progressively less stable, faster replicating PrP(Sc) conformers.

Entities:  

Keywords:  Molecular Evolution; Neurobiology; Neurodegeneration; Prions; Protein Conformation; Sporadic Creutzfeldt-Jakob Disease

Mesh:

Substances:

Year:  2013        PMID: 23974118      PMCID: PMC3795283          DOI: 10.1074/jbc.M113.500108

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  62 in total

1.  Aggregation and fibrillization of the recombinant human prion protein huPrP90-231.

Authors:  W Swietnicki; M Morillas; S G Chen; P Gambetti; W K Surewicz
Journal:  Biochemistry       Date:  2000-01-18       Impact factor: 3.162

Review 2.  Shattuck lecture--neurodegenerative diseases and prions.

Authors:  S B Prusiner
Journal:  N Engl J Med       Date:  2001-05-17       Impact factor: 91.245

3.  Virus-like interference in the latency and prevention of Creutzfeldt-Jakob disease.

Authors:  Laura Manuelidis; Zhi Yun Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-11       Impact factor: 11.205

4.  Selective amplification of classical and atypical prions using modified protein misfolding cyclic amplification.

Authors:  Natallia Makarava; Regina Savtchenko; Ilia V Baskakov
Journal:  J Biol Chem       Date:  2012-11-20       Impact factor: 5.157

5.  Abbreviated incubation times for human prions in mice expressing a chimeric mouse-human prion protein transgene.

Authors:  Carsten Korth; Kiyotoshi Kaneko; Darlene Groth; Norbert Heye; Glenn Telling; James Mastrianni; Piero Parchi; Pierluigi Gambetti; Robert Will; James Ironside; Cornelia Heinrich; Patrick Tremblay; Stephen J DeArmond; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-08       Impact factor: 11.205

6.  Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice.

Authors:  Jiri G Safar; Michael Scott; Jeff Monaghan; Camille Deering; Svetlana Didorenko; Julie Vergara; Haydn Ball; Giuseppe Legname; Estelle Leclerc; Laura Solforosi; Hana Serban; Darlene Groth; Dennis R Burton; Stanley B Prusiner; R Anthony Williamson
Journal:  Nat Biotechnol       Date:  2002-10-21       Impact factor: 54.908

Review 7.  Sporadic human prion diseases: molecular insights and diagnosis.

Authors:  Gianfranco Puoti; Alberto Bizzi; Gianluigi Forloni; Jiri G Safar; Fabrizio Tagliavini; Pierluigi Gambetti
Journal:  Lancet Neurol       Date:  2012-07       Impact factor: 44.182

8.  Genetic influence on the structural variations of the abnormal prion protein.

Authors:  P Parchi; W Zou; W Wang; P Brown; S Capellari; B Ghetti; N Kopp; W J Schulz-Schaeffer; H A Kretzschmar; M W Head; J W Ironside; P Gambetti; S G Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

9.  Small protease sensitive oligomers of PrPSc in distinct human prions determine conversion rate of PrP(C).

Authors:  Chae Kim; Tracy Haldiman; Krystyna Surewicz; Yvonne Cohen; Wei Chen; Janis Blevins; Man-Sun Sy; Mark Cohen; Qingzhong Kong; Glenn C Telling; Witold K Surewicz; Jiri G Safar
Journal:  PLoS Pathog       Date:  2012-08-02       Impact factor: 6.823

10.  Acquisition of drug resistance and dependence by prions.

Authors:  Anja M Oelschlegel; Charles Weissmann
Journal:  PLoS Pathog       Date:  2013-02-07       Impact factor: 6.823

View more
  33 in total

1.  Diagnostic and prognostic value of human prion detection in cerebrospinal fluid.

Authors:  Aaron Foutz; Brian S Appleby; Clive Hamlin; Xiaoqin Liu; Sheng Yang; Yvonne Cohen; Wei Chen; Janis Blevins; Cameron Fausett; Han Wang; Pierluigi Gambetti; Shulin Zhang; Andrew Hughson; Curtis Tatsuoka; Lawrence B Schonberger; Mark L Cohen; Byron Caughey; Jiri G Safar
Journal:  Ann Neurol       Date:  2017-01       Impact factor: 10.422

2.  Rapidly progressive Alzheimer's disease features distinct structures of amyloid-β.

Authors:  Mark L Cohen; Chae Kim; Tracy Haldiman; Mohamed ElHag; Prachi Mehndiratta; Termsarasab Pichet; Frances Lissemore; Michelle Shea; Yvonne Cohen; Wei Chen; Janis Blevins; Brian S Appleby; Krystyna Surewicz; Witold K Surewicz; Martha Sajatovic; Curtis Tatsuoka; Shulin Zhang; Ping Mayo; Mariusz Butkiewicz; Jonathan L Haines; Alan J Lerner; Jiri G Safar
Journal:  Brain       Date:  2015-02-15       Impact factor: 13.501

Review 3.  Prion Strain Diversity.

Authors:  Jason C Bartz
Journal:  Cold Spring Harb Perspect Med       Date:  2016-12-01       Impact factor: 6.915

4.  Glycans are not necessary to maintain the pathobiological features of bovine spongiform encephalopathy.

Authors:  Alicia Otero; Tomás Barrio; Hasier Eraña; Jorge M Charco; Marina Betancor; Carlos M Díaz-Domínguez; Belén Marín; Olivier Andréoletti; Juan M Torres; Qingzhong Kong; Juan J Badiola; Rosa Bolea; Joaquín Castilla
Journal:  PLoS Pathog       Date:  2022-10-07       Impact factor: 7.464

Review 5.  Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.

Authors:  Julie A Moreno; Glenn C Telling
Journal:  Methods Mol Biol       Date:  2017

6.  Prion formation, but not clearance, is supported by protein misfolding cyclic amplification.

Authors:  Ronald A Shikiya; Thomas E Eckland; Alan J Young; Jason C Bartz
Journal:  Prion       Date:  2014       Impact factor: 3.931

7.  Distinct prion-like strains of amyloid beta implicated in phenotypic diversity of Alzheimer's disease.

Authors:  Mark Cohen; Brian Appleby; Jiri G Safar
Journal:  Prion       Date:  2016       Impact factor: 3.931

8.  Prion seeding activity and infectivity in skin samples from patients with sporadic Creutzfeldt-Jakob disease.

Authors:  Christina D Orrú; Jue Yuan; Brian S Appleby; Baiya Li; Yu Li; Dane Winner; Zerui Wang; Yi-An Zhan; Mark Rodgers; Jason Rarick; Robert E Wyza; Tripti Joshi; Gong-Xian Wang; Mark L Cohen; Shulin Zhang; Bradley R Groveman; Robert B Petersen; James W Ironside; Miguel E Quiñones-Mateu; Jiri G Safar; Qingzhong Kong; Byron Caughey; Wen-Quan Zou
Journal:  Sci Transl Med       Date:  2017-11-22       Impact factor: 17.956

Review 9.  Environmental and host factors that contribute to prion strain evolution.

Authors:  Jason C Bartz
Journal:  Acta Neuropathol       Date:  2021-04-25       Impact factor: 17.088

10.  Structurally distinct external solvent-exposed domains drive replication of major human prions.

Authors:  Mohammad Khursheed Siddiqi; Chae Kim; Tracy Haldiman; Miroslava Kacirova; Benlian Wang; Jen Bohon; Mark R Chance; Janna Kiselar; Jiri G Safar
Journal:  PLoS Pathog       Date:  2021-06-17       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.